Home | Products | COVID-19 Research Tools | HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line

HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line

Safely study the SARS-CoV-2 nucleocapsid protein with our ready-to-use HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line.

  • Leverage SBI’s robust lentivector expression technology to study the SARS-CoV-2 nucleocapsid protein
  • Ready-to-use stable cell line accelerates your SARS-CoV-2 studies
  • The overexpression lentivector is also available as plasmid and pre-packaged virus
Catalog Number
Description
Size
Price
Quantity
Add to Cart
CVD19-220A-1
HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line
2 x 10^6 Cells
$ 3199

Overview

Advance your COVID-19 studies with SBI

Explore interactions of the SARS-CoV-2 nucleocapsid protein with host proteins and more using the HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line. Built using our SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, this stable cell line overexpresses the SARS-CoV-2 “N” protein—the nucleocapsid—from the CMV promoter, with a separate EF1α promoter driving expression of the puromycin resistance gene for selection.

  • Leverage SBI’s robust lentivector expression technology to study the SARS-CoV-2 nucleocapsid protein
  • Ready-to-use stable cell line accelerates your SARS-CoV-2 studies
  • The overexpression lentivector is also available as plasmid and pre-packaged virus

 

See all of our COVID-19-related Expression Constructs

Catalog NumberConstruct
CVD19-100PA/VA-1ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-120PA/VA-1SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-130PA/VA-1SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-135PA/VA-1SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Plasmid or Pre-packaged Lentivirus)
CVD19-200A-1HEK293 ACE2 Stable Cell Line
CVD19-220A-1HEK293 "N" SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line

Supporting Data

Figure 1. The SARS-CoV-2 nucleocapsid protein is well expressed in the HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line. We transduced the SARS-CoV-2 Nucleocapsid Overexpression Lentivector (pCDH-CMV-SARS-CoV-2-N-EF1α-Puro) into HEK293 cells to create the stable cell line. To demonstrate the robust expression of the nucleocapsid protein in this cell line, we extracted total protein and analyzed nucleocapsid protein expression via western blot. The parental HEK293 cells display no nucleocapsid expression whereas the HEK293 “N” SARS-CoV-2 Nucleocapsid Overexpression Stable Cell Line possesses robust nucleocapsid expression.

Have Questions?

A System Biosciences technical expert is happy to help!

(888) 266-5066 or Contact Us

Sign up to receive technical advice and exclusive deals directly to your inbox.